# Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia

> **NCT05486377** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 96 (actual)

## Conditions studied

- Remimazolam
- Desflurane
- Cryoablation
- Arrhythmia
- General Anesthesia

## Interventions

- **DRUG:** Remimazolam besylate

## Key facts

- **NCT ID:** NCT05486377
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-02
- **Primary completion:** 2023-05-19
- **Final completion:** 2023-05-19
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486377, "Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05486377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*